Abbott announces FDA approval of Tendyne TMVR system

Abbott (ABT) announced the U.S. FDA has approved the company’s Tendyne transcatheter mitral valve replacement system to treat people with mitral valve disease. This life-changing therapy is available for patients whose mitral valves are not functioning properly due to severe mitral annular calcification, a buildup of calcium within the ring-like structure that supports the mitral valve.